高度創傷ケア市場- 世界の産業規模、シェア、動向、機会、予測、製品別、用途別、エンドユーザー別、地域別、競合、2020-2030Fセグメント別

高度創傷ケアの世界市場規模は2024年に111億8,000万米ドル、2030年には148億米ドルに達し、予測期間中のCAGRは4.75%で成長すると予測されています。

同市場は、慢性および急性創傷の増加、革新的な創傷ケア製品への需要の高まり、医療技術の継続的な進歩などにより、着実な成長を遂げています。高度創傷ケアは、従来の方法と比較してより早く、より効率的な治癒結果をもたらし、病院と在宅ケアの両方で広く採用されています。この分野には、生体活性ドレッシング材、陰圧創傷治療、その他の高性能ソリューションなど、多様な製品が含まれます。世界の需要は旺盛であるが、特に高齢化社会と慢性疾患を持つ人々の間では、製品コストの高さが価格に敏感な地域での幅広い採用の妨げとなっています。

市場促進要因

胆道疾患の増加

主な市場課題

高度創傷ケア製品の高コスト

主要市場動向

再生医療と生物製剤への注目の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 高度創傷ケア市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（保湿、抗菌、活性）
  • 用途別（慢性創傷、急性創傷）
  • エンドユーザー別（病院、専門クリニック、在宅ヘルスケア、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の高度創傷ケア市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の高度創傷ケア市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の高度創傷ケア市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の高度創傷ケア市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの高度創傷ケア市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の高度創傷ケア市場：SWOT分析

第14章 競合情勢

• Convatec Group PLC
• Smith+Nephew
• Molnlycke AB
• B. Braun SE
• 3M Company
• Urgo Group
• Coloplast Corp
• Integra LifeSciences Corporation
• Medline Industries, LP.
• Boston Scientific Corporation.

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Advanced Wound Care Market was valued at USD 11.18 billion in 2024 and is projected to reach USD 14.80 billion by 2030, growing at a CAGR of 4.75% during the forecast period. The market has seen steady growth, largely driven by the increasing prevalence of chronic and acute wounds, the rising demand for innovative wound care products, and ongoing advancements in medical technology. Advanced wound care offers faster, more efficient healing outcomes compared to traditional methods and is widely adopted in both hospital and home care settings. The sector includes diverse offerings such as bioactive dressings, negative pressure wound therapy, and other high-performance solutions. Despite strong global demand, especially in aging populations and among those with chronic conditions, high product costs continue to hinder broader adoption in price-sensitive regions.

Key Market Drivers

Increasing Incidence of Biliary Diseases

The growing incidence of chronic and acute wounds is a central factor accelerating the global advanced wound care market. Globally, chronic wounds affect approximately 1.51 to 2.21 individuals per 1,000 people, representing a substantial segment of patients requiring long-term care. Chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are often linked to underlying conditions such as diabetes, cardiovascular disease, and obesity. These wounds typically do not respond to standard dressings and demand advanced treatment solutions like antimicrobial dressings, hydrogels, and negative pressure wound therapy to prevent severe complications. The increasing burden of noncommunicable diseases-accounting for over 43 million deaths in 2021-further elevates the demand for effective and technologically advanced wound care products across both developed and emerging markets.

Key Market Challenges

High Cost of Advanced Wound Care Products

A significant challenge to the expansion of the advanced wound care market is the high cost of products like negative pressure wound therapy systems and collagen-based dressings. These premium solutions often exceed the budget constraints of healthcare providers in low- and middle-income countries. The elevated price points not only restrict access for individual patients but also strain public health budgets and insurance systems, limiting adoption even in moderately developed regions. As affordability remains a barrier, companies must focus on creating cost-effective alternatives without compromising on efficacy to enhance market penetration.

Key Market Trends

Increasing Focus on Regenerative Medicine and Biologics

A notable trend shaping the advanced wound care market is the increasing integration of regenerative medicine and biologics into wound treatment. Solutions such as growth factors, stem cell therapies, and bioengineered dressings are gaining traction for their ability to promote faster healing, particularly in chronic wound cases. These biologic therapies address underlying healing deficiencies, offering improved outcomes and reducing complications. Healthcare providers are showing a growing preference for such high-efficacy treatments, and companies investing in these biologic-based innovations are poised to benefit from expanding market opportunities as demand for sophisticated, targeted therapies increases.

Key Market Players

• Convatec Group PLC
• Smith+Nephew
• Molnlycke AB
• B. Braun SE
• 3M Company
• Urgo Group
• Coloplast Corp
• Integra LifeSciences Corporation
• Medline Industries, LP.
• Boston Scientific Corporation

Report Scope:

In this report, the Global Advanced Wound Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Advanced Wound Care Market, By Product:

• Moist
• Antimicrobial
• Active

Advanced Wound Care Market, By Application:

• Chronic Wounds
• Acute Wounds

Advanced Wound Care Market, By End User:

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Advanced Wound Care Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Advanced Wound Care Market.

Available Customizations:

Global Advanced Wound Care market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Advanced Wound Care Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Moist, Antimicrobial, Active)
  • 5.2.2. By Application (Chronic Wounds, Acute Wounds)
  • 5.2.3. By End User (Hospitals, Specialty Clinics, Home Healthcare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Advanced Wound Care Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Advanced Wound Care Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Advanced Wound Care Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Advanced Wound Care Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Advanced Wound Care Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Advanced Wound Care Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Advanced Wound Care Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Advanced Wound Care Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Advanced Wound Care Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Advanced Wound Care Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Advanced Wound Care Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Advanced Wound Care Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Advanced Wound Care Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Advanced Wound Care Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Advanced Wound Care Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Advanced Wound Care Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Advanced Wound Care Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Advanced Wound Care Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Advanced Wound Care Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Advanced Wound Care Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Advanced Wound Care Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Advanced Wound Care Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Advanced Wound Care Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Advanced Wound Care Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Advanced Wound Care Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Convatec Group PLC
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Smith+Nephew
• 14.3. Molnlycke AB
• 14.4. B. Braun SE
• 14.5. 3M Company
• 14.6. Urgo Group
• 14.7. Coloplast Corp
• 14.8. Integra LifeSciences Corporation
• 14.9. Medline Industries, LP.
• 14.10.Boston Scientific Corporation.

15. Strategic Recommendations

16. About Us & Disclaimer